Archived article
Please note that tax, investment, pension and ISA rules can change and the information and any views contained in this article may now be inaccurate.
DXS International PLC - Leicestershire, England-based healthcare information and clinical decision support systems - Swings to a pretax loss of £98,645 in the year which ended April 30 from a profit of £253,673 the year before. Revenue falls 8.3% to £3.3 million from £3.6 million. Attributes revenue decrease to a one-off EU sale of £110,000 in the previous year, and a loss of two clients due to NHS restructuring. Expects revenue increase due to increased pricing as a result of GPITF accreditation.
‘Although the past two-and-a-half years have been challenging, we remain more optimistic than ever about the prospects of significant future growth for DXS, both in the UK and internationally,’ Chief Executive David Immelman says.
‘This enthusiasm is fuelled by the global healthcare sector having no alternative but to embrace new ways of working such as remote and virtual consultations and improving efficiencies to manage huge backlogs of patient care. The healthcare market is now showing unequivocal signs that healthcare organisations and clinicians have accepted that digital health solutions are essential to achieving improved healthcare delivery and outcomes. And that data is fast becoming a key driver of enhanced efficiencies.’
Current stock price: 10.1 pence
12-month change: down 16%
Copyright 2022 Alliance News Limited. All Rights Reserved.